28 reports

MARKET ##.

  • Diagnostics
  • Genetic Testing
  • Medical Biotechnology
  • Europe
  • Demand

REST OF WORLD PART D: ANNEXURE ##.

  • Diagnostics
  • In Vitro Diagnostics
  • Europe
  • World
  • Market Size

REST OF WORLD PART D: ANNEXURE ##.

  • Biopsy
  • Diagnostics
  • Australasia
  • Europe
  • Market Shares

On the basis of technology the tissue diagnostic market is classified as immune histochemistry, in-situ hybridization, digital pathology and special staining.

  • Diagnostics
  • APAC
  • Australasia
  • Europe
  • Market Size
  • EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 9.7.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

The partnership will use advanced analytics offered by GE along with Roche' s tissue pathology, genomics, biomarker and sequencing portfolio.

  • Diagnostics
  • Australasia
  • Europe
  • Forecast
  • Market Size

EUROPE IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Europe
  • 12.7 AGILENT TECHNOLOGIES 12.7.1 Key Facts

FIGURE ##.

  • Diagnostics
  • Australasia
  • Europe
  • Market Size
  • Agilent Technologies, Inc.

This system requires every government facility, contracted private imaging center or pathology laboratory to provide certain standardized information that is recorded in SISMAMA prior to reimbursement.

  • Diagnostics
  • Australasia
  • Europe
  • Southeast Asia
  • Forecast

After the tax credit of £##. ## ## m (## ## :£##. ##m), the loss after taxation for the period was £##. ##m(2014: £##. ##m).

  • Biomarker
  • Diagnostics
  • Genomics Proteomics And Enabling Technology
  • Europe
  • Proteome Sciences

European Market Report for Traditional Blood Glucose Monitoring 2016 - MedCore TABLE OF CONTENTS I LIST OF FIGURES IV LIST OF CHARTS V EXECUTIVE SUMMARY ## EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY ## COMPETITIVE ANALYSIS ## MARKET TRENDS ## MARKET DEVELOPMEN

  • Diagnostics
  • Point Of Care Testing
  • Europe

Pap smear test is typically performed by the practice assistant and the collected sample is analyzed at a pathology laboratory.

  • Diagnostics
  • Australasia
  • Europe
  • Western Europe
  • Forecast
  • Vendor landscape

Offers solutions for home glucose testing, laboratory testing, autoimmunity, urinalysis, and cell pathology.

  • Diagnostics
  • Europe
  • Beckman Coulter, Inc.
  • Roche Group
  • Thermo Fisher Scientific, Inc.
  • DIASORIN

The company operates its business in two divisions, namely: BUSINESS SEGMENTATION Molecular diagnostics ##% Immunodiadnostics ##% Instrument sales and revenues ##% These tests enable the immune system to hunt pathologies in the human fluid sample.

  • Diagnostics
  • In Vitro Diagnostics
  • Australasia
  • Europe
  • DiaSorin S.p.A.
  • Vendor landscape

Offers solution for home glucose testing and laboratory testing, autoimmunity, urinalysis, and cell pathology.

  • Diagnostics
  • Australasia
  • Europe
  • Alere Inc.
  • Roche Group

It also offers products specifically tailored for in vitro diagnostics, mainly customized for the cancerous pathologies, as well as for the metabolic and autoimmune diseases.

  • Diagnostics
  • Australasia
  • Europe
  • Beckman Coulter, Inc.
  • DiaSorin S.p.A.
  • LIST OF FIGURES
  • MAY 01, 2017: GENERA BIOSYSTEMS: QUARTERLY CASH FLOW & BUSINESS UPDATE FOR THE PERIOD ENDED 31 MARCH 2017

IT COLLABORATES WITH PATHOLOGY CUSTOMERS AND IVD COMPANIES.

  • Diagnostics
  • Australasia
  • Europe
  • India
  • Genera Biosystems Limited
  • Deal Type
  • Deal Type

Genetic Signatures' product pathogen detection kits provide hospital and pathology laboratories with the molecular tools to screen for infectious pathogens in a rapid and high-throughput environment.

  • Diagnostics
  • Australasia
  • Europe
  • Deals & Alliance
  • Demand

The company provides treatments for vestibular and cochlear pathologies.

  • Diagnostics
  • Ear Disease
  • Pharmaceutical
  • Europe
  • Sensorion S.A.

Its use will be extended to more pathologies and to serve both our research and clinical departments.

  • Diagnostics
  • Genomics
  • Europe
  • United States
  • Genomic Vision SA

Its use will be extended to more pathologies and to serve both our research and clinical departments.

  • Diagnostics
  • Genomics
  • Europe
  • United States
  • Genomic Vision SA
  • 10.3 AGILENT TECHNOLOGIES, INC. 10.3.1 Key Facts

FIGURE ##.

  • Diagnostics
  • Australasia
  • Europe
  • Forecast
  • Agilent Technologies, Inc.

OUR NEW ZEALAND PATHOLOGY DIVISION DELIVERED ANOTHER STRONG RESULT.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Australasia
  • Europe
  • Forecast

We are highly committed to continue to invest in our pathology segment by opening new pathology labs and through acquisitions. "

  • Diagnostics
  • Europe
  • Poland
  • Deals & Alliance
  • M&A

OUR NEW ZEALAND PATHOLOGY DIVISION DELIVERED ANOTHER STRONG RESULT.

  • Diagnostics
  • Australasia
  • Australia
  • Europe
  • Alere Inc.

The new systems provide the same sample compartment width as Shimadzu' s standard model while being only one third of its size.

  • Diagnostics
  • Australasia
  • Europe
  • Deals & Alliance
  • Shimadzu Corporation

" A SIMPLE ONE-STEP ALGORITHM TO DETECT TOXIGENIC C.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Point Of Care Testing
  • Europe
  • Product Initiative
  • Anatomic Pathology LIS
  • Clinical Pathology LIS

Clinical diagnostic laboratories Hospitals Anatomic pathology laboratories Cerner Corporation Sunquest Information Systems Compugroup Medical AG ## ##. ## Sources: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MicroMarketMonitor Analysis % ## ##

  • Diagnostics
  • In Vitro Diagnostics
  • Australasia
  • Europe
  • Cerner Corporation